CGC Canopy Growth Corp

As we approach the mid-term elections and marijuana legalization once again becomes a topic of debate, $CGC is a good chart to keep an eye on. Huge triangle and pretty close to breaking out. If it can reclaim its 50 DMA, watch out above 📈🌿 Pretty likely $1+ is coming again in the near future

$CGC Another major argument against legalization is falling apart. According to a new CDC study, teen marijuana use has reached an all-time low even as more states legalize cannabis for adults. Regulation and proper age controls can work better than prohibition. Another strong argument for cannabis reform and Schedule III. 🌿🇺🇸

$CGC 🚀 Canopy Growth Expands Internationally! 🇦🇺🌿 CGC is expanding its medical cannabis portfolio in Australia with new products and formulations across Spectrum Therapeutics, 7ACRES, Tweed and Twd. While everyone is focused on Schedule III, Canopy continues building its international business in the background. More products + expanding global presence + potential U.S. cannabis reform = a powerful combination. 🔥📈 Another positive step forward for Canopy Growth. Bullish! 🐂🌿 $CGC

$CGC back over the 50 mda with volume. Needs to hold. Company finally doing some positive PR activity. Luc posted a video from London today with the announcement on LinkedIn.

$CGC Why is the judge taking his sweat time in moving cannabis to schedule 3? We’re coming up to a month and no decision…wtf? Unless he’s contemplating removing it from the control substance list entirely, we need him to get on with it.

$CGC Possible "October Surprise" 😇 before the midterm elections aside, if Dems seize control of both Houses of Congress, Trump will still be able to push S3 up until Congress is seated in 2027. If Trump fails, Congress will be able to legalize weed entirely with no input from the DEA required, thus giving the Congressional Dems a big PR Mandingo bone. As such, it looks like there's a 34 - 130 day +/- window of opportunity that people will be smoking weed in the streets forevermore. I could be wrong .🫪🧐

$CGC Great to see Canopy Growth strengthening its presence in Germany 🇩🇪 Welcoming a dedicated Country Manager is another positive step as the company builds on the opportunity in Europe’s medical cannabis market. More focus, stronger local execution and room to grow. Bullish on Canopy’s international potential!

$CGC I for one an sick of these companies using reverse splits to clean up their mess, it’s legal robbery of shareholders value and the SEC should not allow it to continue. There is nothing to incentivize management to run correctly if they can just keep erasing shares and killing shareholders value hoping they can entice new investors! Hey long time investors, thanks for your support, as a reward we are making it 15 x harder to get even !!

$CGC - MONDAY WE HOLD. NO ONE SELLS.* We've been pushed down long enough. Too many shorts, too much fear, too many paper hands. From Monday, NOBODY sells. Let it finally run up. Let the shorts sweat for once. This is it. NOW OR NEVER. HOLD THE LINE.

$CGC Well let’s hope the management uses this month to raise the share price instead of just trying to change shareholders minds! No one wants another reverse split, do the work to raise the stock price naturally by adding value. If that means cutting staff or selling assets then do it! Stop making the sacrifices all the common shareholders burden!

$CGC The meeting was adjourned. it will be on October 23. previous authorization for reverse split expired. for the following month none has authority for reverse split. if alj recommendation comes until October 23 a reverse split vote might be irelevant.

$CGC curious if Canada joining the EU as an associate member could help with cannabis sales. Maybe it reduces costs by being a member.

$CGC added $6K worth today. This is ridiculous. So many positives that if this can show positive EBIDA this will sky rocket to $2.50 - $2.90.

$CGC If Trump wants to capitalize on probable momentum from S3 heading into the November 4 midterm elections, he'll put his thumb on the scale (urge, cajole, coerce, threaten behind-the-scene movers & shakers / molders & shapers to release the "Reschedule Qracken" or some such affectation. If he doesn't he knows the distinct possibility/probability of congressional Democrats seizing the issue by the horns could cost him dearly...

$CGC looks like they failed to get approved for the reverse split, I guess the shareholders have an issue with their value being cut by 15

$CGC Damn i almost threw 10k in on this yesterday in hopes of a quick little pop. maybe someday I'll be better at pulling triggers

$CGC This has to he the oddest industry to invest in. The world knows that rescheduling is almost a done deal. But this industry is trading at ATL’s WTF?

$CGC good grief. Price action makes no sense from a financial perspective. Seems like pure manipulation to ensure the reverse split happens.

$CGC Hoping for the best but expecting the worst, are you gonna drop the bomb or not?🎶🎶 How can something so nice be this disapointing. I guess with this stock timing the market beats the time in the market. Nobody knows how far it will still fall because this stock is manipulated as f*. Worst choice of mine but still after all this time i believe in what cannabis stands for. When the time is right this thing will fly. But the time of guessing WHEN this could happen is over. I lost eventhough this dead money stays where it is. Expecting something from a purely random thing is the worst you can do. That's my take of this stock.

$CGC announced an agreement to supply four Canadian-grown medical cannabis flower strains for distribution in the United Kingdom, marking the company's official market entry into the UK. Under the agreement, the Canadian-grown flower will be supplied to GROW Group U.K. Ltd., a distributor of prescribed cannabis-based medicines across Europe. GROW Group will commercialize and distribute the products across the UK under Canopy Growth’s global Spectrum Therapeutics medical brand. The expansion builds on the recent renewal of European Union Good Manufacturing Practice (EU GMP) certification at Canopy Growth’s cultivation facility in Kincardine, Ontario, which enables the company to export medical cannabis across European markets...